(1R,4R)-4-(Ethoxycarbonyl)cyclohexanecarboxylic acid, 95.0%, 1g

2-Amino-3-(2,3-dichlorophenyl)propanoic acid, 95+%, 5g

2-(1-BENZYL-PIPERIDIN-3-YL)-3-NITRO-PROPIONIC ACID ETHYL ESTER, 95.0%, 250mg

2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid, 98.0%, 100g

2-(4-(Benzyloxy)-3-methoxyphenyl)acetic acid, 98%, 1g

Recipientes esterilizables en autoclave con tapa rectangular, 42 l, 1 unidad

3-Chloro-2-(4-iodophenoxy)-5-(trifluoromethyl)pyridine, 95.0%, 1g

(S)-(+)-3-Piperidinecarboxylic Acid>98.0%(T)5g

N-Benzylaminomethyltrimethylsilane, 95%, 25g

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-S-[(4-methoxyphenyl)diphenylmethyl]-L-cysteine, 97%, 1g

16-Aminohexadecanoic acid, 98%, 1g

1-Benzyl 3-tert-butyl azetidine-1,3-dicarboxylate, 95.0%, 500mg

2-{[4-(2-Chlorobenzoyl)piperazin-1-yl]carbonyl}benzoic acid, 90.0%, 1g